Clinical and laboratory factors associated with neurosyphilis and the diagnostic performance of cerebrospinal fluid markers: a retrospective observational study
This retrospective observational study of 281 syphilis patients identified cerebrospinal fluid IgG as the most discriminative marker for neurosyphilis, achieving an AUC of 0.902 with 79.2% sensitivity and 91.0% specificity at a cutoff of 54.7, while also highlighting age, serum glucose, CSF albumin, WBC count, Pandy's test, and the CSF/serum albumin quotient as significant associated factors.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Syphilis is a bacterial infection that, if left untreated, can travel beyond the skin and blood to invade the nervous system. When this happens, it is called neurosyphilis, a condition that can cause severe damage to the brain and spinal cord. Doctors have long known that standard blood tests can confirm a person has syphilis, but they have struggled to find a single, perfect test to prove the bacteria has reached the brain. The current way to diagnose this dangerous stage involves looking at the fluid that surrounds the brain and spinal cord, known as cerebrospinal fluid. However, because no single marker acts as a universal gold standard, doctors must piece together clues from various lab results and patient history to make a diagnosis. This uncertainty can lead to delays in treatment, which is critical because the infection can cause lasting neurological harm if not addressed quickly.
To help clarify this diagnostic puzzle, researchers at two hospitals in Anhui, China, looked back at the medical records of 281 patients who had syphilis and underwent a spinal tap to examine their cerebrospinal fluid. The team wanted to see which specific factors in the patients' blood and spinal fluid were most strongly linked to the presence of neurosyphilis. They divided the patients into two groups: those who met the local guidelines for having neurosyphilis and those who had syphilis but no signs of the infection in their nervous system. By comparing these two groups, the researchers hoped to identify which lab values were the most reliable indicators of the disease.
The study revealed that patients with neurosyphilis were, on average, older and more likely to be male than those without the condition. When the researchers examined the laboratory results, they found that several measurements in the spinal fluid were significantly different between the two groups. Patients with the nervous system infection had higher levels of white blood cells, higher protein levels, and a specific chemical reaction known as Pandy's test that turned positive much more frequently. In the blood, patients with neurosyphilis also tended to have higher glucose levels. However, when the researchers used a statistical method to see which factors were truly independent predictors of the disease, they found that age, blood glucose, and several spinal fluid markers remained significant, while other blood factors like creatinine did not.
Among all the indicators tested, one stood out as the most powerful tool for distinguishing between patients with and without neurosyphilis. The level of a specific protein called immunoglobulin G in the spinal fluid showed the strongest ability to separate the two groups. This protein, which is part of the body's immune defense, was found to be much higher in patients with the infection. When the researchers tested a specific threshold for this protein, they found it could correctly identify nearly 80 percent of the patients with neurosyphilis while correctly ruling out 91 percent of those without it. This performance was better than that of other common markers like total protein or white blood cell count in the spinal fluid.
The researchers noted that while this protein level is a very strong clue, it should not be used alone to make a diagnosis. It works best when combined with other test results and the patient's overall clinical picture. The study also highlighted that the findings apply specifically to patients who do not have HIV, as those with the virus were excluded from the analysis to avoid complicating the results. Because this was a review of past records from a single region, the authors suggest that the results need to be confirmed by looking at new patients in different places. Nevertheless, the study provides a clearer picture of which routine lab tests offer the most useful information when doctors are trying to determine if syphilis has invaded the nervous system.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.